1-Bromopropane


Curated chemical-gene interactions from CTD
Entrez gene IDGene symbolInteraction typeReference
10476 ATP5PD Decreases expression PMID:21925529
11315 PARK7 Decreases expression PMID:21925529
1152 CKB Decreases expression PMID:21925529
12716 CKMT1 Decreases expression PMID:21925529
1385 CREB1 Decreases activity PMID:19189864
146713 RBFOX3 Increases expression PMID:30247689
1536 CYBB Increases expression PMID:27452781
1728 NQO1 Increases expression PMID:20211940
18 ABAT Decreases expression PMID:21925529
1812 DRD1 Decreases expression PMID:19576243
1813 DRD2 Decreases expression PMID:19576243
1891 ECH1 Decreases expression PMID:21925529
2100 ESR2 Increases expression PMID:27634370
2554 GABRA1 Decreases expression PMID:19576243
2566 GABRG2 Increases expression PMID:19576243
26227 PHGDH Increases expression PMID:21925529
2729 GCLC Increases expression PMID:20211940
2730 GCLM Increases expression PMID:20211940
2875 GPT Increases activity PMID:17265426
2890 GRIA1 Increases expression PMID:32715571
2908 NR3C1 Decreases expression PMID:23266320
2936 GSR Decreases activity PMID:23395825
2936 GSR Increases expression PMID:20211940
2940 GSTA3 Increases expression PMID:21925529
2950 GSTP1 Increases expression PMID:21925529
3162 HMOX1 Increases expression PMID:20211940
3187 HNRNPH1 Decreases expression PMID:21925529
3309 HSPA5 Increases expression PMID:21925529; PMID:27421776
3329 HSPD1 Increases expression PMID:21925529
3350 HTR1A Decreases expression PMID:19576243
3356 HTR2A Decreases expression PMID:19576243
3358 HTR2C Increases expression PMID:19576243
3359 HTR3A Affects expression PMID:19576243
3553 IL1B Increases expression PMID:18164123
3569 IL6 Increases expression PMID:18164123
383 ARG1 Increases expression PMID:30247689
4780 NFE2L2 Decreases expression PMID:27452781
4790 NFKB1 Increases activity PMID:18164123
4843 NOS2 Increases expression PMID:18164123; PMID:30247689
5682 PSMA1 Decreases expression PMID:21925529
5743 PTGS2 Increases activity PMID:22353212
5743 PTGS2 Increases expression PMID:22353212
5901 RAN Increases expression PMID:21925529; PMID:27421776
5970 RELA Increases activity PMID:18164123; PMID:30247689
598 BCL2L1 Decreases expression PMID:16815550
627 BDNF Decreases expression PMID:19189864; PMID:23266320
6323 SCN1A Increases expression PMID:32715571
6387 CXCL12 Increases expression PMID:23384675
6647 SOD1 Decreases expression PMID:27452781
6648 SOD2 Decreases expression PMID:27452781
7124 TNF Increases expression PMID:18164123
7167 TPI1 Affects expression PMID:21925529
8125 ANP32A Increases expression PMID:21925529
847 CAT Decreases expression PMID:27452781
8839 CCN5 Increases expression PMID:23384675
9512 PMPCB Decreases expression PMID:21925529
9615 GDA Decreases expression PMID:21925529

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.